MCDS - ETF AI Analysis
Top Page
JPMorgan Fundamental Data Science Mid Core ETF (MCDS)
MCDS, the JPMorgan Fundamental Data Science Mid Core ETF, has a solid overall rating driven by strong contributors like Westinghouse Air Brake Technologies, State Street, and M&T Bank, which show healthy financial performance, positive technical trends, and supportive earnings outlooks. The fund’s score is held back somewhat by weaker names such as Snowflake and Hewlett Packard Enterprise, where profitability, valuation concerns, and some bearish or overbought technical signals add risk. The main risk factor is exposure to several holdings with high valuations and profitability challenges, which could increase volatility if market conditions worsen.
MCDS vs. SPDR S&P 500 ETF (SPY)
- AUM
- 8.16M
- Region
- North America
- Expense Ratio
- 0.35%
- Beta
- 0.84
- Issuer
- JPMorgan
- Inception Date
- Aug 08, 2024
- Dividend Yield
- 1.02%
- Asset Class
- Equity
- Index Tracked
- No Underlying Index
MCDS Summary
The JPMorgan Fundamental Data Science Mid Core ETF (MCDS) focuses on U.S. mid-sized companies and does not track a traditional index, instead using data science to pick stocks it believes have solid finances and good growth potential. It spreads investments across many sectors, including technology, health care, and financials, with holdings such as Marathon Petroleum and Hewlett Packard Enterprise. Someone might invest in this ETF to seek long-term growth while diversifying beyond large, well-known companies. A key risk is that mid-cap stocks can be more volatile, so the ETF’s value can go up and down more than the overall market.
How much will it cost me?
This ETF has an expense ratio of 0.35%, which means you’ll pay about $3.50 per year for every $1,000 you invest. That’s a bit higher than the average low-cost index ETF because it uses an actively managed, data-science-driven strategy to pick mid-cap stocks rather than simply tracking a basic market index.
What would affect this ETF?
This U.S.-focused mid-cap ETF could benefit if the economy grows steadily, supporting sectors like technology, industrials, and health care, and if data-driven stock picking helps identify strong companies such as Marathon Petroleum, Hewlett Packard Enterprise, and Snowflake. On the downside, higher interest rates, a U.S. economic slowdown, or sector-specific issues in energy, financials, or real estate could hurt mid-cap stocks and reduce the effectiveness of its data science strategy.
MCDS Top 10 Holdings
This mid-cap ETF leans into U.S. industrials, energy, tech, and financials, with a few names doing the heavy lifting. Marathon Petroleum has been a key engine, rising steadily and giving the fund a boost from the energy side. In health care, Natera has been climbing, adding some growth flair, while Cardinal Health provides a steadier, more defensive counterweight. On the tech front, Snowflake and Hewlett Packard Enterprise have shown mixed, sometimes lagging momentum, occasionally acting as a brake. State Street and M&T Bank round out a solid financial backbone, keeping the fund broadly diversified but U.S.-centric.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 MPC | Marathon Petroleum | 1.84% | $150.08K | $124.89B | 127.33% | 66Neutral |
 NTRA | Natera | 1.37% | $111.62K | $59.72B | 114.42% | 73Outperform |
 HPE | Hewlett Packard Enterprise | 1.36% | $111.03K | $73.13B | 125.69% | 68Neutral |
 CAH | Cardinal Health | 1.20% | $98.18K | $58.00B | 31.94% | 66Neutral |
 STT | State Street | 1.09% | $88.79K | $46.19B | 47.34% | 75Outperform |
 SNOW | Snowflake | 1.05% | $85.87K | $107.99B | 12.87% | 54Neutral |
 WAB | Westinghouse Air Brake Technologies | 1.05% | $85.38K | $46.92B | 37.64% | 79Outperform |
 DGX | Quest Diagnostics | 0.98% | $79.92K | $27.71B | 43.28% | 79Outperform |
 DOV | Dover | 0.97% | $79.10K | $27.63B | 15.32% | 79Outperform |
MCDS Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For MCDS, the sentiment is Positive. The current price of 67.16 is above the 20-day moving average (MA) of 66.67, above the 50-day MA of 66.68, and above the 200-day MA of 64.45, indicating a bullish trend. The MACD of 0.23 indicates Negative momentum. The RSI at 54.12 is Neutral, neither overbought nor oversold. The STOCH value of 84.89 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for MCDS.
MCDS Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| MCDS | $67.16 | $72.00(7.21% Upside) | $8.16M | 0.35% | 68Neutral |
 KMID | $24.37 | $28.88(18.52% Upside) | $52.99M | 0.80% | 71Outperform |
 MMID | $27.47 | $31.72(15.47% Upside) | $37.52M | 0.59% | 68Neutral |
 SMCP | $25.65 | $29.55(15.20% Upside) | $13.56M | 0.79% | 71Outperform |
 TMID | $25.62 | $31.64(23.50% Upside) | $11.68M | 0.47% | 63Neutral |
 REMC | $23.27 | $26.90(15.63% Upside) | $5.91M | 0.32% | 69Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| MCDS | JPMorgan Fundamental Data Science Mid Core ETF | 67.16 | 10.09 | 17.67% | |
| KMID | Virtus KAR Mid-Cap ETF | 24.37 | 0.09 | 0.36% | |
| MMID | MFS Active Mid Cap ETF | 27.47 | 3.17 | 13.05% | |
| SMCP | SMART Mid Cap ETF | 25.65 | 0.78 | 3.14% | |
| TMID | T. Rowe Price Mid Cap Equity Research ETF | 25.62 | 0.37 | 1.48% | |
| REMC | Columbia Research Enhanced Mid Cap ETF | 23.27 | 2.76 | 13.47% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.